Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
1861
Tikoo K, Ali IY, Gupta J and Gupta C. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats Toxicology Letters 2009, 191, 158-166.
1862
Tikoo K, Kumar P and Gupta J. Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats. BMC Cancer 2009, 9, (107) .
1863
Tripathi DN and Jena GB. Intervention of astaxanthin against cyclophosphamide-induced oxidative stress and DNA damage: A study in mice Chemico-Biological Interactions 2009, 180, 398-406.
1864
Vats P, Bhushan B and Banerjee UC. Studies on the dephosphorylation of phytic acid in livestock feed using phytase from Aspergillus niger van Teighem Bioresource Technology 2009, 100, 287-291.
1865
Adyary F, P ivi O, Gupta H, Pia B, Anna G, Mohan CG and Pia MV. Inhibition of acetylcholinesterase by coumarins: The case of coumarin 106 Pharmacological Research 2008, 58, 215-221.
1866
Agrawal V and Roy N. Contaminating insert degradation by preincubation colony PCR: A method for avoiding false positives in transformant screening Analytical Biochemistry 2008, 375, 159-161.
1867
Agrawal V, Gupta B, Banerjee UC and Roy N. A method for construction, cloning and expression of intron-less gene from unannotated genomic DNA Molecular Biotechnology 2008, 40, 217-223.
1868
Arora M, Kumar A, Kaundal R and Sharma SS. Amelioration of Neurological and Biochemical Deficits by Peroxynitrite Decomposition Catalysts in Experimental Diabetic neuropathy European Journal of Pharmacology 2008, 596, 77-83.
1869
Ashokraj Y, Agrawal S and Panchagnula R. A decision tree for rapid quality assurance and control of rifampicin-containing oral dosage forms for global distribution for tuberculosis treatment Indian Journal of Pharmaceutical Sciences 2008, 70, 4-1.
1870
Ashokraj Y, Kaur KJ, Singh I, Kholi G, Bhade SR, Varma MVS, Agrawal S and Panchagnula R. In vivo dissolution: predominant factor affecting the bioavailability of rifampicin from its solid oral dosage forms Clinical Research and Regulatory Affairs 2008, 25, 12-1.
1871
Awale M and Mohan CG. 3D-QSAR CoMFA analysis of C5 substituted pyrrolotriazines as HER2 (ErbB2) inhibitors Journal of Molecular Graphics and Modelling 2008, 26, 1169-1178.
1872
Awale M and Mohan CG. Molecular Docking Guided 3D-QSAR CoMFA Analysis of N-4-Pyrimidinyl-1H-indazol-4-amine Inhibitors of Leukocyte-specific protein tyrosine kinase Journal of Molecular Modeling 2008, 14, 937-947.
1873
Bahiru LA and Bharatam PV. Tautomeric preferences and electron delocalisation in biurets, thiobiuret and dithiobiuret: an ab initio quantum chemical study International Journal of Quantum Chemistry 2008, 108, 1277-1286.
1874
Bansal SS, Kaushal A and Bansal AK. Co-relationship of physical stability of amorphous dispersions with enthalpy relaxation Die Pharmazie 2008, 63, 812-814.
1875
Bhagat S and Chakraborti AK. Zirconium(IV) compounds as efficient catalysts for synthesis of α-aminophosphonates Journal of Organic Chemistry 2008, 73, 6029-6032.
Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|125|15